Author

Stephen R. Plymate

University of WashingtonORCID 0000-0002-7597-6943Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Adam SharpiD· 1 shared Alessandro BarberisiD· 1 shared Amanda SwainiD· 1 shared Ana FerreiraiD· 1 shared Andrew C.B. CatoiD· 1 shared Antje NeebiD· 1 shared Bissan Al‐LazikaniiD· 1 shared Bora GüreliD· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Adam SharpORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression

Silvia Daniele Rodrigues, Caroline F. Ribeiro, Giuseppe Nicolò Fanelli, Isadora Ferrari Teixeira, Alessandro Barberis, Hubert Pakula, Pier Vitale Nuzzo, Filippo Pederzoli, Fabio Socciarelli, Sara Bleve, Jeanne Jiang, Jonas Dehairs, Guilherme Henrique Tamarindo, Giorgia Zadra, Lisa M. Butler, , Massimo F. Loda

This study shows that inhibiting de novo lipogenesis and supplementing with PUFAs suppresses prostate cancer progression by inducing oxidative stress and cell death.

bioRxiv · Sep 21, 2026 · PreprintCancer Biology

Targeting the BAG-1 family of co-chaperones in lethal prostate cancer.

Antje Neeb, Ines Figueiredo, Denisa Bogdan, Laura Cato, Jutta Stober, Juan M. Jiménez‐Vacas, Victor Gourain, Irene I. Lee, Rebecca Seeger, Claudia Muhle‐Goll, Bora Gürel, Jonathan C. Welti, Daniel Nava Rodrigues, Jan Rekowski, Xintao Qiu, , Adam Sharp

This study investigates Thio-2's mechanism of action in inhibiting AR signaling in CRPC, showing it acts independently of BAG-1 isoforms and with potential AR NTD binding.

bioRxiv · Oct 17, 2022 · PreprintMolecular Biology